• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Insilico & Teva Enter Collaboration

    Achillion Expands with Launch of PA Office

    AGC, Calypso Form Devt./Mfg. Deal

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Achillion Expands with Launch of PA Office

    ACG Capsules Expands in Brazil

    AGC, Calypso Form Devt./Mfg. Deal

    APC Expands to U.S. with Opening of MA Facility

    Catalent Enters Clinical Supply Partnership with Adial
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Insilico & Teva Enter Collaboration

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Aphena Pharma Solutions, Inc.

    Vetter Pharma International GmbH

    Ascendia Pharmaceuticals

    Jubilant HollisterStier Contract Manufacturing & Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Ascendia Pharmaceuticals

    Ajinomoto Bio-Pharma Services

    Alcami

    Federal Equipment Company

    Emergent BioSolutions, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    PCI Expands Controlled Substance Storage Capacity

    Stands ready to support packaging changes brought on by new opioid legislation

    PCI expands blister packaging capacity for opioids.
    PCI expands blister packaging capacity for opioids.
    Related CONTENT
    • Athersys Appoints Mfg. SVP
    • PCI Expands Cold Chain Infrastructure
    • Pharma Packaging Solutions
    • TAPI Announces New President
    • PCI Acquires Sherpa Clinical Packaging
    01.22.19
    PCI Pharma Services (PCI) has made another investment in its infrastructure for packaging of controlled substances, complementing its capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited quantity unit dose packaging as a tactic to combat substance misuse.
     
    PCI has extended onsite controlled substance storage at its U.S. commercial packaging locations in Philadelphia, PA and Rockford, IL, and will undertake further expansions as demand increases. PCI supports DEA Schedule I-V controlled substances for both commercial prescription medicines, as well as those for investigational clinical trials, with approximately two million square feet of dedicated packaging infrastructure across the two locations.
     
    Child resistant unit dose blister packaging has been a key focus of discussion in U.S. opioid reform measures. PCI says it has immediate capacity for the introduction of new unit dose blister packaging in formats conducive to meeting the stringent child resistant requirements required by opioids. According to the company, it can support more than five billion unit dose blister packs annually.
     
    “There has been considerable discussion about the opportunity for utilizing blister packaging as one tool to positively influence the misuse of opioid and pain management medications in the U.S.,” said Phil DiGiacomo, senior vice president, sales and marketing, PCI. “A critical factor in that narrative is to ensure safety in the home. Opioid packaging demands the highest levels of child resistance. PCI is in a unique position to make this specialized packaging immediately available by virtue of our proven, highly automated, high-speed solutions, helping our pharmaceutical clients in their transition to meet the latest legislative requirements. These child resistant packaging solutions protect younger people in the home, and provide an adherence platform supporting the user to take medication as prescribed.”
    Related Searches
    • www.contractpharma.com
    • marketing
    • prescription
    • Pharma
    Suggested For You
    PCI Invests $20M in Biotech & Advanced Injectable Delivery Forms PCI Invests $20M in Biotech & Advanced Injectable Delivery Forms
    PCI Expands Clinical Services Biz PCI Expands Clinical Services Biz
    Reed-Lane, Inc. Reed-Lane, Inc.
    CMIC Details Services & Growth CMIC Details Services & Growth
    PCI Marks 80th Serialization Installation PCI Marks 80th Serialization Installation
    PCI Appoints Executive Director of Operations PCI Appoints Executive Director of Operations
    DCAT Elects President DCAT Elects President
    Vetter To Expand Secondary Packaging Vetter To Expand Secondary Packaging
    PCI Launches New Returns Management Facility PCI Launches New Returns Management Facility
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Pharma Packaging Solutions Pharma Packaging Solutions
    3DP Dosage Forms and the Future of Drug Lifecycle Management 3DP Dosage Forms and the Future of Drug Lifecycle Management
    PCI Pharma Services to Acquire Sherpa Clinical Packaging  PCI Pharma Services to Acquire Sherpa Clinical Packaging
    Jones Contract Packaging Services Jones Contract Packaging Services
    PCI Acquires Sherpa Clinical Packaging PCI Acquires Sherpa Clinical Packaging

    Related Breaking News

    • Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
      Insilico & Teva Enter Collaboration

      Insilico & Teva Enter Collaboration

      To apply Insilico’s technology for predictive biomanufacturing to create & execute more efficient production processes of Teva’s biopharmaceutical therapeutics
      02.21.19

    • Bio News | Facilities | Industry News
      Achillion Expands with Launch of PA Office

      Achillion Expands with Launch of PA Office

      The approximately 12,000 square-feet office space will serve as Achillion’s executive offices and clinical operations base
      02.21.19

    • Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
      AGC, Calypso Form Devt./Mfg. Deal

      AGC, Calypso Form Devt./Mfg. Deal

      Enter agreement for process development and cGMP manufacture of CALY-002
      02.20.19


    • Bio News | Drug Delivery | Industry News | Promotions & Moves
      Quanticate Appoints SVP of Project Delivery

      Quanticate Appoints SVP of Project Delivery

      Paula Finch has over 20 years’ experience of working in statistics and SAS programming for sponsor companies and CROs
      02.20.19

    • Breaking News | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Alkermes, Clovis Form Cancer Research Collaboration

      Alkermes, Clovis Form Cancer Research Collaboration

      Together will explore combination cancer therapies
      02.20.19

    • Bio News | Facilities | Industry News | Methods Development | Process Development
      APC Expands to U.S. with Opening of MA Facility

      APC Expands to U.S. with Opening of MA Facility

      Business Development, Marketing and Project Management services will operate from the new office space, with possible lab space planned for the future
      02.20.19


    • Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Pii Inks Devt. Deal with Nemus

      Pii Inks Devt. Deal with Nemus

      CDMO to develop dosage formulation for human dosing with NB1111 for glaucoma
      02.20.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
      Evotec & HZI Parnter for Novel Antibiotics

      Evotec & HZI Parnter for Novel Antibiotics

      Research activities will initially be focused on the optimization of cystobactamids
      02.20.19

    • Analytical Services | Bio News | Collaborations & Alliances | Industry News | Information Technology | R&D
      WuXi STA, BioLingus Form Technology Collaboration

      WuXi STA, BioLingus Form Technology Collaboration

      WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the CDMO sector
      02.20.19


    • Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News

      Gliknik Receives $15M Milestone from Pfizer

      Follows start of Phase 1 trial for Pfizer candidate PF-06755347
      02.20.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      PPD & HLT Enter Development Agreement

      PPD & HLT Enter Development Agreement

      To create data science-driven clinical research solutions in China with the goal of enhancing global drug development
      02.20.19

    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Packaging & Tracking
      Catalent Enters Clinical Supply Partnership with Adial

      Catalent Enters Clinical Supply Partnership with Adial

      Will package and distribute Adial’s AD04 for its Phase 3 trial
      02.20.19

    • Breaking News | Capsules | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
      Catalent Receives P&G Award

      Catalent Receives P&G Award

      Recognizes the performance of softgel manufacturing facilities in Canada
      02.20.19

    • Breaking News | Promotions & Moves
      BASi Appoints COO

      BASi Appoints COO

      Oakley responsible for leading operations at BASi’s three sites in West Lafayette and Evansville, IN, and St. Louis, MO
      02.19.19

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    Breaking News
    • Insilico & Teva Enter Collaboration
    • Achillion Expands with Launch of PA Office
    • AGC, Calypso Form Devt./Mfg. Deal
    • Quanticate Appoints SVP of Project Delivery
    • Alkermes, Clovis Form Cancer Research Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login